Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Biochemical and Biophysical Research Communications|December 4, 1996
Self-assembly of the brain MAP-2 microtubule-binding region into polymeric structures resembling Alzheimer filamentsE Y Zhang, M A DeTure, M R Bubb, et al.Antiviral Research|February 1, 1993
The structure and function of the HSV DNA replication proteins: defining novel antiviral targetsJ T Matthews, B J Terry, A K FieldMolecular Pharmacology|October 1, 1991
Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1 alpha,2 beta,3 alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl] guanineB J Terry, C W Cianci, M E HagenThe Journal of Biological Chemistry|August 25, 1983
Thermodynamic parameters governing interaction of EcoRI endonuclease with specific and nonspecific DNA sequencesB J Terry, W E Jack, R A Rubin, et al.Virus Genes|April 1, 1990
Neutralization of purified herpes simplex virus DNA polymerase by two antipeptide seraJ T Matthews, J T Stevens, B J Terry, et al.Journal of Virology|December 1, 1988
Expression of herpes simplex virus type 1 DNA polymerase in Saccharomyces cerevisiae and detection of virus-specific enzyme activity in cell-free lysatesM L Haffey, J T Stevens, B J Terry, et al.Proceedings of the National Academy of Sciences of the United States of America|February 20, 1996
Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitorsR E Rose, Y F Gong, J A Greytok, et al.Antiviral Research|December 1, 1988
Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPGB J Terry, K E Mazina, A V Tuomari, et al.Antiviral Research|January 1, 1990
(+-)-(1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)-cyclobutyl] guanine [(+-)-BHCG or SQ 33,054]: a potent and selective inhibitor of herpesvirusesA K Field, A V Tuomari, B McGeever-Rubin, et al.Antimicrobial Agents and Chemotherapy|July 18, 2000
BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agentsB S Robinson, K A Riccardi, Y F Gong, et al.Pageof 7